Åvall-Lundqvist E - Search Results

1

Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study.

Bjurberg M, Holmberg E, Borgfeldt C, Flöter-Rådestad A, Dahm-Kähler P, Hjerpe E, Högberg T, Kjølhede P, Marcickiewicz J, Rosenberg P, Stålberg K, Tholander B, Hellman K, Åvall-Lundqvist E. Bjurberg M, et al. Gynecol Oncol. 2019 Nov;155(2):229-236. doi: 10.1016/j.ygyno.2019.08.022. Epub 2019 Aug 30. Gynecol Oncol. 2019. PMID: 31477283

2

Vaginal changes and sexuality in women with a history of cervical cancer.

Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Bergmark K, et al. N Engl J Med. 1999 May 6;340(18):1383-9. doi: 10.1056/NEJM199905063401802. N Engl J Med. 1999. PMID: 10228188 Free article.

3

Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.

Silins I, Avall-Lundqvist E, Tadesse A, Jansen KU, Stendahl U, Lenner P, Zumbach K, Pawlita M, Dillner J, Frankendal B. Silins I, et al. Gynecol Oncol. 2002 May;85(2):333-8. doi: 10.1006/gyno.2002.6628. Gynecol Oncol. 2002. PMID: 11972397

4

Patient-rating of distressful symptoms after treatment for early cervical cancer.

Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Bergmark K, et al. Acta Obstet Gynecol Scand. 2002 May;81(5):443-50. doi: 10.1034/j.1600-0412.2002.810512.x. Acta Obstet Gynecol Scand. 2002. PMID: 12027819 Free article.

5

A population-based study of cervical carcinoma and HPV infection in Latvia.

Silins I, Wang X, Tadesse A, Jansen KU, Schiller JT, Avall-Lundqvist E, Frankendal B, Dillner J. Silins I, et al. Gynecol Oncol. 2004 May;93(2):484-92. doi: 10.1016/j.ygyno.2004.01.044. Gynecol Oncol. 2004. PMID: 15099967

6

Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.

Hernlund E, Hjerpe E, Avall-Lundqvist E, Shoshan M. Hernlund E, et al. Mol Cancer Ther. 2009 Jul;8(7):1916-23. doi: 10.1158/1535-7163.MCT-09-0179. Epub 2009 Jun 30. Mol Cancer Ther. 2009. PMID: 19567816

7

Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study.

Lind H, Waldenström AC, Dunberger G, al-Abany M, Alevronta E, Johansson KA, Olsson C, Nyberg T, Wilderäng U, Steineck G, Åvall-Lundqvist E. Lind H, et al. Br J Cancer. 2011 Sep 6;105(6):737-45. doi: 10.1038/bjc.2011.315. Epub 2011 Aug 16. Br J Cancer. 2011. PMID: 21847122 Free PMC article.

8

Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.

Wintzell M, Hjerpe E, Åvall Lundqvist E, Shoshan M. Wintzell M, et al. BMC Cancer. 2012 Aug 18;12:359. doi: 10.1186/1471-2407-12-359. BMC Cancer. 2012. PMID: 22901285 Free PMC article.

9

HSP60 predicts survival in advanced serous ovarian cancer.

Hjerpe E, Egyhazi S, Carlson J, Stolt MF, Schedvins K, Johansson H, Shoshan M, Avall-Lundqvist E. Hjerpe E, et al. Int J Gynecol Cancer. 2013 Mar;23(3):448-55. doi: 10.1097/IGC.0b013e318284308b. Int J Gynecol Cancer. 2013. PMID: 23429486

10

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer.

Hjerpe E, Egyhazi Brage S, Carlson J, Frostvik Stolt M, Schedvins K, Johansson H, Shoshan M, Avall-Lundqvist E. Hjerpe E, et al. BMC Clin Pathol. 2013 Nov 19;13(1):30. doi: 10.1186/1472-6890-13-30. BMC Clin Pathol. 2013. PMID: 24252137 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page